ArticleBlood advances2022

Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly "promising"?

Andrew M Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.